An Open Label Phase I Substudy to Evaluate the Safety and Ability to Enhance Immunogenicity of ND1.1 by Delivery Directly to the Ileum Using the InteliSite Companion Capsule in Healthy Adult Males [Substudy of 700054364]
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2015
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions
- 14 Jul 2015 Data will be presented at the Society for Mucosal Immunology Conference 2015, according to a Vaxart media release.
- 09 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jul 2013 New trial record